generic drugs | Zee News

Advertisement

Newsgeneric drugs

Generic drugs News

01 May 2017

'Govt needs to phase out branded drugs to promote generic medications'

Days after PM Modi's announcement, the Medical Council of India (MCI) had directed all the hospitals, doctors and state medical council to prescribe generic medicines to patients.

22 Apr 2017

DNA: MCI cracks the whip on errant hospitals, doctors; directs them to prescribe generic drugs

The implication of this directive is huge as India moves to mitigate healthcare costs across the nation.

generic medicines

22 Apr 2017

MCI directs hospitals, doctors across India to prescribe generic medicines to patients

This move comes few days after Prime Minister Narendra Modi urged at bringing a legal framework under which generic medicines should be given by the doctors and the healthcare system in India should have an extensive reach so that drugs are made available to all the people.

18 Apr 2017

Generic drugs: Are they as effective as brand-name versions?

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, safety, route of administration, quality, performance, intended use and risks.

18 Apr 2017

Modi govt aims to break doctor-pharma company nexus, medicines will become cheaper

We will bring in a legal framework by which if a doctor writes a prescription, he has to write in it that it will be enough for patients to buy generic medicine and he need not buy any other medicine, he said.

22 Aug 2015

Germany suspends marketing of 54 drugs tested by India's GVK Bio

Germany has suspended marketing of 54 drugs tested by GVK Biosciences in compliance with the European Union's ban on around 700 generic drugs.

27 Jul 2015

EU suspends sale of 700 generic drugs made in India

European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU`s executive confirmed on Monday.

27 Jul 2015

Pharmexcil sees $1.2 billion export hit from EU ban

India's business loss arising from the European Union's ban on 700 generic drugs is likely to be around USD 1.2 billion, says industry body Pharmexcil.

01 Jun 2015

Lupin, Cipla bid for UCB's US generic drugs portfolio: Report

Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.

Endo International

18 May 2015

Endo to buy Par Pharmaceutical for $8.05 billion

Endo International will buy Par Pharmaceutical Holdings in a $8.05 billion deal that will strengthen Endo`s generic drugs business, the companies said Monday.

GVK Biosciences Pvt Ltd

16 Apr 2015

India may take WTO action against EU over drug clinical trials: GVK

The privately-held company, part of India`s infrastructure builder GVK Group, conducts clinical research for domestic and foreign drugmakers.

Swiss pharmaceuticals

27 Jan 2015

Novartis profits jump 12% on new drug sales

Swiss pharmaceuticals giant Novartis said Tuesday strong sales of new products helped push its net profit up 12 percent last year despite harsh competition from cheaper copycat generic drugs.

08 Dec 2014

GVK Bio offers to re-do studies after EU ruling

Pharmaceutical research company GVK Biosciences has offered to re-do studies at its own cost after the European Union suspended marketing approval of some generic drugs due to alleged manipulation of data related to clinical trials.

06 Dec 2014

France, Germany suspend some drug approvals over Indian data

All of the drugs being suspended, several of which are manufactured by Mylan Inc and Abbott , have brand name equivalents that can be used instead, so patients will not have to interrupt their treatment.

Ranbaxy Laboratories

26 Nov 2014

US court refuses Ranbaxy appeal to block ANDA nod for 2 drugs

Drug firm Ranbaxy Laboratories on Wednesday said the DC Federal Court in the US has not granted the company temporary restraining order to block the US health regulator from approving other ANDAs for generic versions of digestive disorder medicine Nexium and anti-viral Valcyte.

Ranbaxy Laboratories Ltd

20 Nov 2014

US denies Ranbaxy's bid to block launch of rival generics

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc`s heartburn pill Nexium and Roche`s antiviral, a court filing showed.

20 Nov 2014

US court overturns bid by Ranbaxy to block launch of rival generic drugs

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc`s heartburn pill Nexium and Roche`s antiviral Valcyte.

India pharmaceutical industry

12 Nov 2014

Indian drugmakers see US sales hit by delay in new approvals

Leading Indian generic drugmakers Dr Reddy`s Laboratories Ltd and Glenmark Pharmaceuticals Ltd this month posted a drop in their second-quarter US sales

13 Jun 2014

Lupin launches generic Ciprofloxacin in US market

The company had earlier received final approval for the product from the USFDA.

Loading...

NEWS ON ONE CLICK